Traws Pharma, Inc.TRAWNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank15
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
-33.41
↓ 822% vs avg
Percentile
P15
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
4.63
Historical baseline
PeriodValueYoY Change
2024-33.41-48.6%
2023-22.48+79.8%
2022-111.36-107.2%
2021-53.75-119.8%
2020271.74+3536.9%
2019-7.91-17.4%
2018-6.73-155.9%
201712.04+685.7%
2016-2.06-1259.5%
20150.18-